SAN FRANCISCO, Dec. 22, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care
solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming
35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
iRhythm’s management is scheduled to present on Wednesday, January 11, 2017 at 11:00am PT. Interested parties may access a
webcast of the presentation on the “Investor Relations” section of the company’s website at: www.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a commercial-stage digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The
company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary
algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements
in arrhythmia detection and characterization have the potential to change clinical management of patients. The company’s platform,
the Zio Service, has been provided to over 500,000 patients, accumulating more than 125 million hours of curated heartbeat data
within iRhythm’s data repository.
Investor Relations Contact: Lynn Pieper Lewis or Leigh Salvo (415) 937-5404 investors@irhythmtech.com Media Contact Aaron Murphy (415) 229-3331 media@irhythmtech.com
